mRNA Cancer Vaccines and Therapeutics Market 

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Due to the COVID-19 pandemic, the global mRNA Cancer Vaccines and Therapeutics market size is estimated to be worth US$ 140.4 million in 2021 and is forecast to a readjusted size of US$ 140.4 million by 2028 with a CAGR of 19.0% during the review period.

Fully considering the economic change by this health crisis, by Type accounting for % of the mRNA Cancer Vaccines and Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Type segment is altered to an % CAGR throughout this forecast period.

North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.

The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.

The global mRNA Cancer Vaccines and Therapeutics market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global mRNA Cancer Vaccines and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

By Type

• Adeno Carcinomas
• Mucinous Carcinomas
• Adenosquamous Carcinomas

By Application

• Infectious Disease
• Cancer
• Others

By Region

• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Other Regions

By Company

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology